KR100320772B1 - Process for Preparation of (S)-Benzoxazine Derivatives and Process for Racemization of (R)-Benzoxazine Derivatives - Google Patents
Process for Preparation of (S)-Benzoxazine Derivatives and Process for Racemization of (R)-Benzoxazine Derivatives Download PDFInfo
- Publication number
- KR100320772B1 KR100320772B1 KR1019990016338A KR19990016338A KR100320772B1 KR 100320772 B1 KR100320772 B1 KR 100320772B1 KR 1019990016338 A KR1019990016338 A KR 1019990016338A KR 19990016338 A KR19990016338 A KR 19990016338A KR 100320772 B1 KR100320772 B1 KR 100320772B1
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- benzoxazine
- dihydro
- alkyl
- dihalogeno
- Prior art date
Links
- 230000006340 racemization Effects 0.000 title claims abstract description 12
- 238000000034 method Methods 0.000 title claims description 18
- 238000002360 preparation method Methods 0.000 title description 12
- 150000001875 compounds Chemical class 0.000 claims abstract description 66
- PVTXJGJDOHYFOX-UHFFFAOYSA-N 2h-1,4-benzoxazine Chemical compound C1=CC=C2N=CCOC2=C1 PVTXJGJDOHYFOX-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000002253 acid Substances 0.000 claims abstract description 16
- RZWZRACFZGVKFM-UHFFFAOYSA-N propanoyl chloride Chemical compound CCC(Cl)=O RZWZRACFZGVKFM-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000003960 organic solvent Substances 0.000 claims abstract description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 8
- 125000001153 fluoro group Chemical group F* 0.000 claims description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 150000005130 benzoxazines Chemical class 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- -1 [1,4] benzoxazine racemate compound Chemical class 0.000 claims 3
- 238000010306 acid treatment Methods 0.000 claims 2
- 230000003301 hydrolyzing effect Effects 0.000 claims 1
- 238000011084 recovery Methods 0.000 claims 1
- CMLFRMDBDNHMRA-UHFFFAOYSA-N 2h-1,2-benzoxazine Chemical compound C1=CC=C2C=CNOC2=C1 CMLFRMDBDNHMRA-UHFFFAOYSA-N 0.000 abstract description 10
- 239000012044 organic layer Substances 0.000 abstract description 10
- 239000000243 solution Substances 0.000 abstract description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract description 8
- 238000006243 chemical reaction Methods 0.000 abstract description 8
- 239000000463 material Substances 0.000 abstract description 7
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 abstract description 6
- 239000012454 non-polar solvent Substances 0.000 abstract description 5
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 abstract description 3
- 238000001914 filtration Methods 0.000 abstract description 2
- 239000011259 mixed solution Substances 0.000 abstract description 2
- 239000011260 aqueous acid Substances 0.000 abstract 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 18
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- 230000003287 optical effect Effects 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 239000002904 solvent Substances 0.000 description 7
- 239000007787 solid Substances 0.000 description 6
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 4
- 239000012267 brine Substances 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- 229930182820 D-proline Natural products 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 229960003376 levofloxacin Drugs 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- BVHSAZFNVBBGNX-YFKPBYRVSA-N (3s)-7,8-difluoro-3-methyl-3,4-dihydro-2h-1,4-benzoxazine Chemical class C1=CC(F)=C(F)C2=C1N[C@@H](C)CO2 BVHSAZFNVBBGNX-YFKPBYRVSA-N 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
- 238000004293 19F NMR spectroscopy Methods 0.000 description 2
- BVHSAZFNVBBGNX-UHFFFAOYSA-N 7,8-difluoro-3-methyl-3,4-dihydro-2h-1,4-benzoxazine Chemical compound C1=CC(F)=C(F)C2=C1NC(C)CO2 BVHSAZFNVBBGNX-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- ONIBWKKTOPOVIA-SCSAIBSYSA-N D-Proline Chemical compound OC(=O)[C@H]1CCCN1 ONIBWKKTOPOVIA-SCSAIBSYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000002274 desiccant Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- BVHSAZFNVBBGNX-RXMQYKEDSA-N (3r)-7,8-difluoro-3-methyl-3,4-dihydro-2h-1,4-benzoxazine Chemical compound C1=CC(F)=C(F)C2=C1N[C@H](C)CO2 BVHSAZFNVBBGNX-RXMQYKEDSA-N 0.000 description 1
- AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 description 1
- KLTMALVMVMGIGT-UHFFFAOYSA-N 2-methyl-4h-1,4-benzoxazine Chemical compound C1=CC=C2OC(C)=CNC2=C1 KLTMALVMVMGIGT-UHFFFAOYSA-N 0.000 description 1
- YRLORWPBJZEGBX-UHFFFAOYSA-N 3,4-dihydro-2h-1,4-benzoxazine Chemical class C1=CC=C2NCCOC2=C1 YRLORWPBJZEGBX-UHFFFAOYSA-N 0.000 description 1
- 229930182821 L-proline Natural products 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- MIOPJNTWMNEORI-MHPPCMCBSA-N [(4r)-7,7-dimethyl-3-oxo-4-bicyclo[2.2.1]heptanyl]methanesulfonic acid Chemical compound C1C[C@]2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-MHPPCMCBSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical class C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 229960002429 proline Drugs 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 125000005270 trialkylamine group Chemical group 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
(RS)-3-알킬-7,8-디할로게노-2,3-다히드로-4H[1,4]벤족사진 라세미체 화합물과 (S)-2-(6-메톡시나프틸-2-일)프로피오닐 클로라이드를 1 : 0.5∼0.6의 몰비로 유기용매 내에서 혼합하여 반응시키고; 산 수용액을 첨가하여 다량의 (R)-1 화합물이 함유된 미반응물과 N-[(2S)-2-(6-메톡시나프틸-2-일)프로피오닐]-(3S)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진이 함유된 유기층 물질을 분리하고; 상기 유기층 물질을 세척, 건조, 활성탄처리, 여과, 및 감압증류한 후 얼음용기하에서 비극성용매를 가하여 여과함으로써 N-[(2S)-2-(6-메톡시나프틸-2-일]-(3S)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진Ⅰ 화합물과 Ⅱ 화합물을 분리하고; 상기 벤족사진Ⅰ 화합물에 산을 가하여 가수분해함으로써 (S)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진 유도체 (S)-1 화합물을 얻는다. 상기 과정에서 분리된 벤족사진Ⅱ 화합물에 산을 가하여 가수분해하고, 여기에 다량의 (R)-1 화합물을 함유한 상기 미반응물을 가하고, 이 혼합용액에 0.1∼1몰비의 산을 가하여 100∼150℃의 온도에서 5∼20시간동안 라세미화 반응시켜 (RS)-1 라세미체 화합물을 제조한다.(RS) -3-alkyl-7,8-dihalogeno-2,3-dahydro-4H [1,4] benzoxazine racemic compound and (S) -2- (6-methoxynaphthyl- 2-yl) propionyl chloride is reacted by mixing in an organic solvent in a molar ratio of 1: 0.5 to 0.6; Aqueous acid solution containing N-[(2S) -2- (6-methoxynaphthyl-2-yl) propionyl]-(3S) -3- Separating the organic layer material containing alkyl-7,8-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine; The organic layer material was washed, dried, treated with activated carbon, filtered, and distilled under reduced pressure, followed by filtration by adding a nonpolar solvent under an ice container to obtain N-[(2S) -2- (6-methoxynaphthyl-2-yl]-( 3S) -3-alkyl-7,8-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine I compound and compound II were separated; an acid was added to the benzoxazine I compound to hydrolyze it This gives (S) -3-alkyl-7,8-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine derivative (S) -1 compound. An acid was added to the compound to hydrolyze it, and the above unreacted product containing a large amount of (R) -1 compound was added thereto, and 0.1 to 1 molar ratio of acid was added to the mixed solution, and 5 to 20 at a temperature of 100 to 150 ° C. A racemization reaction was performed for a time to prepare a (RS) -1 racemate compound.
Description
발명의 분야Field of invention
본 발명은 (S)-벤족사진(benzoxazine) 유도체의 제조방법 및 (R)-벤족사진 유도체의 라세미화(racemization) 방법에 관한 것이다. 보다 구체적으로 본 발명은 강력한 항균작용을 갖는 레보플록사신(levofloxacin) 및 그 유사 화합물의 제조에 유용한 중간체인 (S)-벤족사진 유도체를 라세미체인 벤족사진(RS)-1 화합물과 분할제로서 (S)-2-(6-메톡시나프틸-2-일)프로피오닐 클로라이드를 반응시켜 제조하고, 상기 (S)-벤족사진 유도체의 제조과정에서 발생되는 화합물과 미반응된 (R)-벤족사진 화합물을 반응시켜 (R)-벤족사진 화합물을 라세미화하는 방법에 관한 것이다.The present invention relates to a method for preparing a (S) -benzoxazine derivative and a racemization method for a (R) -benzoxazine derivative. More specifically, the present invention provides a (S) -benzoxazine derivative, which is a useful intermediate for the preparation of levofloxacin and similar compounds having a strong antimicrobial activity, as a racemic benzoxazine (RS) -1 compound and a splitting agent (S). )-(6-methoxynaphthyl-2-yl) propionyl chloride, and reacted with the compound generated during the preparation of the (S) -benzoxazine derivative. A method of reacting a compound to racemate a (R) -benzoxazine compound.
발명의 배경 및 종래기술Background of the Invention and Prior Art
(S)-벤족사진 유도체의 하나인 (S)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진 유도체 (S)-1 화합물을 제조하기 위한 여러 가지 방법들이 알려져 있다. (S)-벤족사진 유도체는 강력한 항균작용을 갖는 레보플록사신 및 그 유사 화합물의 제조에 유용한 중간체이다.Preparation of (S) -3-alkyl-7,8-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine derivative (S) -1 compound, which is one of the (S) -benzoxazine derivatives Various methods are known for doing this. (S) -benzoxazine derivatives are useful intermediates for the preparation of levofloxacin and similar compounds having potent antibacterial action.
유럽특허 제206,283호에는 L-프롤린의 P-톨루엔설포닐 유도체를 이용한 라세미체 벤족사진 (RS)-1 화합물을 광학 분할하는 방법이 기술되어 있다. 그러나 이 방법은 원하는 벤족사진 유도체(S)-1 화합물을 고광학순도로 얻기 위하여 칼럼 크로마토그래피를 사용하여야 하는 문제가 있다. 또한 상기 특허에는 지방 단백질 리파제(lipase)를 이용하는 광학 이성질체 분리법이 기술되어 있으나 대량 합성법으로는 적합하지 못하다.EP 206,283 describes a method for optically dividing racemate benzoxazine (RS) -1 compounds using P-toluenesulfonyl derivatives of L-proline. However, this method has a problem of using column chromatography to obtain a desired benzoxazine derivative (S) -1 compound with high optical purity. The patent also describes optical isomer separation using fat protein lipase but is not suitable for mass synthesis.
일본공개특허 제1-175,975호에서 D-프롤린의 P-톨루엔설포닐 유도체를 이용한 라세미체 벤족사진 (RS)-1 화합물의 광학 분할법이 기술되어 있으나, 여기서 사용되는 D-프롤린은 비교적 고가이고 라세미체 벤족사진 (RS)-1 화합물 1몰당 1.2몰 이상의 과량을 사용하여야 하기 때문에 제조원가 측면에서 불리하다.Japanese Patent Laid-Open No. 1-175,975 describes the optical cleavage of racemic benzoxazine (RS) -1 compounds using P-toluenesulfonyl derivatives of D-proline, but the D-proline used here is relatively expensive It is disadvantageous in terms of production cost because an excess of 1.2 moles or more per mole of racemic benzoxazine (RS) -1 compound must be used.
유럽특허 제304,684호에는 (R)-(-)-캠퍼-10-설폰산과 라세미체 벤족사진 (RS)-1 화합물의 염형성법을 이용한 광학 이성질체 분리법이 기재되어 있으나, 이 방법으로는 고광학순도의 (S)-1 화합물을 얻을 수 없다.EP 304,684 discloses optical isomer separation using salt formation of (R)-(-)-camphor-10-sulfonic acid and racemic benzoxazine (RS) -1 compounds, but this method is known as high optical Purity (S) -1 compound could not be obtained.
또한 유럽특허 제273,399호와 제368,410호에는 광학 이성질체 합성법이 기재되어 있으나 단계가 복잡하고 수율이 낮으며 고광학순도의 (S)-1 화합물을 얻을 수없다.In addition, European Patent Nos. 273,399 and 368,410 describe optical isomer synthesis methods, but complicated steps, low yields, and high optical purity (S) -1 compounds cannot be obtained.
상기와 같은 문제점을 해결하기 위하여, 본 발명자들은 고광학순도를 갖고 값싸게 (S)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진 유도체(S)-1 화합물을 얻을 수 있는 방법을 개발하기에 이른 것이다.In order to solve the above problems, the present inventors have high optical purity and inexpensively (S) -3-alkyl-7,8-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine It is early to develop a method for obtaining a derivative (S) -1 compound.
본 발명의 목적은 고광학순도를 갖는 (S)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진 유도체 (S)-1 화합물을 얻을 수 있는 방법을 제공하기 위한 것이다.An object of the present invention is to obtain (S) -3-alkyl-7,8-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine derivative (S) -1 compound having high optical purity It is intended to provide a way to do this.
본 발명의 다른 목적은 (S)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진 유도체 (S)-1 화합물을 값싸게 제조할 수 있는 방법을 제공하기 위한 것이다.Another object of the present invention is to provide a (S) -3-alkyl-7,8-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine derivative (S) -1 compound at low cost. It is to provide a way.
본 발명의 또 다른 목적은 (S)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진 유도체 (S)-1 화합물의 제조과정에서 발생하는 미반응된 (R)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진 유도체 (R)-1 화합물을 라세미화하는 방법을 제공하기 위한 것이다.Another object of the present invention arises during the preparation of (S) -3-alkyl-7,8-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine derivative (S) -1 compound To provide a method of racemizing an unreacted (R) -3-alkyl-7,8-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine derivative (R) -1 compound It is for.
본 발명의 상기 및 기타의 목적들은 하기 설명되는 본 발명에 의해 모두 달성될 수 있다.The above and other objects of the present invention can be achieved by the present invention described below.
본 발명에 따른 (S)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진 유도체[(S)-1], (R)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진 유도체[(R)-1] 및 (RS)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진 유도체[(RS)-1]는 하기식으로 표시된다:(S) -3-alkyl-7,8-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine derivatives according to the invention [(S) -1], (R) -3- Alkyl-7,8-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine derivatives [(R) -1] and (RS) -3-alkyl-7,8-dihalogeno- The 2,3-dihydro-4H [1,4] benzoxazine derivative [(RS) -1] is represented by the formula:
상기식에서 X1및 X2는 서로 동일하거나 또는 상이한 할로겐원자이며 바람직하게는 불소원자이고, R은 저급 알킬기이며 바람직하게는 메틸기이다.Wherein X 1 and X 2 are the same or different halogen atoms from each other, preferably a fluorine atom, R is a lower alkyl group, preferably a methyl group.
상기 벤족사진 유도체 (S)-1 화합물은 강력한 항균작용을 갖는 레보플록사신 및 이의 유사화합물의 제조에 유용한 중간체이다.The benzoxazine derivatives (S) -1 compounds are useful intermediates for the preparation of levofloxacin and similar compounds having strong antimicrobial activity.
본 발명자들은 상기 벤족사진 유도체 (RS)-1 라세미체 화합물을 (S)-2-(6-메톡시나프틸-2-일)프로피오닐 클로라이드에 반응시킬 경우 (S)-1 화합물이 (R)-1 화합물보다 상대적으로 반응이 빨리 진행되어 N-[(2S)-2-(6-메톡시나프틸-2-일)프로피오닐]-(3S)-3-알킬-디할로게노-2,3-디히드로-4H[1,4]벤족사진 유도체Ⅰ 화합물이 N-[(2S)-2-(6-메톡시나프틸-2-일)프로피오닐]-(3S)-3-알킬-디할로게노-2,3-디히드로-4H[1,4]벤족사진 유도체Ⅱ 화합물보다 빨리 생성됨을 발견하여 이들 Ⅰ 화합물과 Ⅱ 화합물을 반응속도에 따라 분할할 수 있다는 것을 착안하였다.The inventors have found that when the benzoxazine derivative (RS) -1 racemate compound is reacted with (S) -2- (6-methoxynaphthyl-2-yl) propionyl chloride, the (S) -1 compound is ( The reaction proceeds faster than the R) -1 compound, whereby N-[(2S) -2- (6-methoxynaphthyl-2-yl) propionyl]-(3S) -3-alkyl-dihalogeno- 2,3-Dihydro-4H [1,4] benzoxazine Derivative I Compound is N-[(2S) -2- (6-methoxynaphthyl-2-yl) propionyl]-(3S) -3- It was found to be produced faster than alkyl-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine derivative II compounds and it was conceived that these compounds I and II could be partitioned according to the reaction rate.
상기식에서 X1및 X2는 서로 동일하거나 또는 상이한 할로겐원자이며 바람직하게는 불소원자이고, R은 저급 알킬기이며 바람직하게는 메틸기이다.Wherein X 1 and X 2 are the same or different halogen atoms from each other, preferably a fluorine atom, R is a lower alkyl group, preferably a methyl group.
본 발명에서는 (RS)-1 화합물에 대하여 (S)-2-(6-메톡시나프틸-2-일)프로피오닐 클로라이드를 0.5∼0.6몰비로 반응시킴으로써 Ⅰ 화합물을 Ⅱ 화합물에 비하여 다량 생성하고, 원하는 Ⅰ 화합물을 고체상태로 분리하고, 산을 이용하여 가수분해하여 원하는 (S)-1 화합물을 얻을 수 있다. 본 발명에서는 (S)-2-(6-메톡시나프틸-2-일)프로피오닐 클로라이드를 분할제로 사용하며, 그 사용량은 종래의 방법에서 사용된 분할제의 양보다 거의 절반 이하이다. 따라서 제조원가를 절감할 수 있다. 예를 들어, 일본공개특허 제1-175,975호에서 분할제로 사용된 D-프롤린은 비교적 고가이고 (RS)-1 화합물 1몰당 1.2몰 이상의 과량을 사용하여야 한다.In the present invention, by reacting (S) -2- (6-methoxynaphthyl-2-yl) propionyl chloride with (RS) -1 compound at 0.5 to 0.6 molar ratio, a large amount of compound I is produced compared to compound II. The desired compound I can be separated in the solid state and hydrolyzed with an acid to obtain the desired compound (S) -1. In the present invention, (S) -2- (6-methoxynaphthyl-2-yl) propionyl chloride is used as the dividing agent, and its amount used is almost half or less than the amount of the dividing agent used in the conventional method. Therefore, manufacturing cost can be reduced. For example, D-proline used as a dividing agent in Japanese Patent Laid-Open No. 1-175,975 is relatively expensive and an excess of 1.2 moles or more per mole of (RS) -1 compound should be used.
또한 본 발명에서는 고광학순도를 갖는 (S)-1 화합물을 얻을 수 있다. 종래에는 폐기되던 (R)-1 화합물을 라세미화시켜 재사용 함으로써 수율 및 제조원가 측면에서 본 발명은 장점을 갖는다.In the present invention, the compound (S) -1 having high optical purity can be obtained. The present invention has advantages in terms of yield and production cost by racemizing and reusing the previously discarded (R) -1 compound.
상기 (RS)-1 라세미체 화합물에서 X1과 X2가 불소원자이고, R이 메틸기인 경우에 (S)-2-(6-메톡시나프틸-2-일)프로피오닐 클로라이드를 반응시켜 본 발명에 따른 (S)-1 화합물을 얻고 미반응된 (R)-1 화합물을 라세미화 반응시키는 반응구조는하기식으로 표시된다:(S) -2- (6-methoxynaphthyl-2-yl) propionyl chloride is reacted when X1 and X2 are fluorine atoms and R is a methyl group in the (RS) -1 racemate compound. The reaction structure for obtaining the (S) -1 compound according to the invention and racemizing the unreacted (R) -1 compound is represented by the following formula:
(RS)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진 라세미체 화합물과 (S)-2-(6-메톡시나프틸-2-일)프로피오닐 클로라이드를 1 : 0.5∼0.6몰의 비로 유기용매 내에서 혼합하여 반응시킨다. 유기용매로는 디클로로메탄, 1,2-디클로로에탄, 또는 클로로포름이 이용가능하고, 반응온도는 -10∼40℃의 범위가 바람직하다. 유기용매 내에는 트리알킬아민류 또는 피리딘이 존재할 수도 있다.(RS) -3-alkyl-7,8-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine racemic compound and (S) -2- (6-methoxynaphthyl- 2-yl) propionyl chloride is mixed and reacted in an organic solvent in a ratio of 1: 0.5 to 0.6 mol. Dichloromethane, 1,2-dichloroethane, or chloroform can be used as the organic solvent, and the reaction temperature is preferably in the range of -10 to 40 ° C. Trialkylamines or pyridine may be present in the organic solvent.
상기 반응용액에 산 수용액을 첨가하여 다량의 (R)-1 화합물이 함유된 미반응물과 N-[(2S)-2-(6-메톡시나프틸-2-일)프로피오닐]-(3S)-7,8-디플루오로-2,3-디히드로-3-메틸-4H[1,4]벤족사진이 함유된 유기층 물질을 분리한다. 상기 (R)-1 화합물이 함유된 미반응물은 물층을 형성하는데, 이를 회수하여 라세미화 반응에 재사용한다.An acid solution was added to the reaction solution, and an unreacted substance containing a large amount of (R) -1 compound and N-[(2S) -2- (6-methoxynaphthyl-2-yl) propionyl]-(3S The organic layer material containing) -7,8-difluoro-2,3-dihydro-3-methyl-4H [1,4] benzoxazine is separated. The unreacted material containing the (R) -1 compound forms a water layer, which is recovered and reused in the racemization reaction.
상기 유기층 물질을 세척, 건조, 활성탄처리, 여과 및 감압증류한 후, 얼음용기 하에서 비극성 용매를 가하여 여과함으로써 N-[(2S)-2-(6-메톡시나프틸-2-일)-(3S)-7,8-디플루오로-2,3-디히드로-3-메틸-4H[1,4]벤족사진Ⅰ 화합물과 Ⅱ 화합물을 분리한다. 상기 유기층 물질은 물로써 세척하고, 건조제로써 건조시키고, 활성탄으로 처리한 후 여과하고, 용매는 감압 증류하여 제거한다. 그 다음 얼음용기 하에서 비극성 용매를 가하여 생성된 고체를 여과하면 상기 벤족사진Ⅰ 화합물이 분리된다. 비극성 용매에 함유된 Ⅱ 화합물은 회수하여 라세미화 반응에 재사용한다. 여기서 사용된 비극성 용매로는 헥산이 바람직하다.The organic layer material was washed, dried, treated with activated carbon, filtered, and distilled under reduced pressure, and then filtered by adding a nonpolar solvent under an ice container to obtain N-[(2S) -2- (6-methoxynaphthyl-2-yl)-( 3S) -7,8-difluoro-2,3-dihydro-3-methyl-4H [1,4] benzoxazine I and II compounds are separated. The organic layer material is washed with water, dried with a desiccant, treated with activated charcoal and filtered, and the solvent is removed by distillation under reduced pressure. The solid produced by adding a non-polar solvent under an ice container is then filtered to separate the benzoxazine I compound. Compound II contained in the nonpolar solvent is recovered and reused in the racemization reaction. As the nonpolar solvent used here, hexane is preferable.
상기에서 얻어진 벤족사진Ⅰ 화합물에 산을 가하여 가수분해함으로써 (S)-7,8-디플루오로-2,3-디히드로-3-메틸-4H[1,4]벤족사진 유도체 (S)-1 화합물을 얻는다. 여기서 사용되는 산은 염산, 황산, 초산, 또는 이들의 혼합산이 있다. 상기 벤족사진Ⅰ 화합물에 산을 가하고 가열하면서 환류시킨다. 초산을 사용한 경우에는, 감압증류하여 초산을 제거하고 얼음용기 하에서 물을 첨가한다. 생성되는 고체를 여과하고 물로 세척한다. 여과액은 수산화나트륨 수용액으로 pH를 조절한다. 디클로로메탄으로 상기 용액을 추출하고 소금물로 세척하고 유기층 물질을 건조제로써 건조시키고 여과한다. 용매를 감압증류로 제거하여 노란색의 오일상 (S)-1 화합물을 얻는다.(S) -7,8-difluoro-2,3-dihydro-3-methyl-4H [1,4] benzoxazine derivative (S)-by hydrolysis by addition of an acid to the benzoxazine I compound obtained above 1 compound is obtained. Acids used herein are hydrochloric acid, sulfuric acid, acetic acid, or mixed acids thereof. An acid is added to the benzoxazine I compound and refluxed while heating. If acetic acid is used, distilled under reduced pressure to remove acetic acid and add water under an ice container. The resulting solid is filtered off and washed with water. The filtrate is adjusted to pH with aqueous sodium hydroxide solution. The solution is extracted with dichloromethane and washed with brine and the organic layer material is dried with a desiccant and filtered. The solvent is removed by distillation under reduced pressure to give a yellow oily (S) -1 compound.
상기 과정에서 분리된 벤족사진Ⅱ 화합물에 산을 가하여 가수분해하고, 여기에 다량의 (R)-1 화합물을 함유한 상기 미반응물을 가한다. 이 경우에도 염산, 황산, 초산 또는 이들의 혼합산이 사용될 수 있다. 상기 혼합용액에 0.1∼1몰비의 산을 가하여 100∼150℃의 온도에서 5∼20시간동안 라세미화 반응시켜 (RS)-1 라세미체 화합물을 제조한다. 여기서 사용되는 산으로는 메틸설폰산, 황산 또는 이들의 혼합산이 있으며, 바람직하기로는 120±10℃의 온도에서 8∼14시간동안 라세미화 반응시킨다.An acid is added to the benzoxazine II compound separated in the above step to hydrolyze, and the unreacted substance containing a large amount of (R) -1 compound is added thereto. In this case too, hydrochloric acid, sulfuric acid, acetic acid or mixed acids thereof may be used. To the mixed solution was added 0.1-1 molar ratio of acid, followed by racemization at a temperature of 100-150 ° C. for 5-20 hours to prepare a (RS) -1 racemic compound. The acid used herein is methylsulfonic acid, sulfuric acid or a mixed acid thereof, preferably racemized for 8 to 14 hours at a temperature of 120 ± 10 ℃.
본 발명은 하기의 실시예에 의하여 보다 구체화될 것이며, 하기의 실시예는 본 발명을 예시하기 위한 것으로 본 발명의 보호 범위를 제한하고자 하는 것은 아니다.The invention will be further illustrated by the following examples, which are intended to illustrate the invention and are not intended to limit the protection scope of the invention.
실시예Example
실시예 1a: (S)-2-(6-메톡시나프틸-2-일)프로피오닐 클로라이드의 제조Example 1a: Preparation of (S) -2- (6-methoxynaphthyl-2-yl) propionyl chloride
(S)-2-(6-메톡시나프틸-2-일)프로피온산 19.0g을 250ml의 1,2-디클로로에탄에 녹이고 0.1ml의 디메틸포름아미드와 7.8ml의 티오닐클로라이드를 가하였다. 40℃에서 2.5시간동안 교반한 후 용매와 과량의 티오닐클로라이드를 감압증류 제거하여 20.5g의 목적 생성물을 고체상으로 수득하였다.19.0 g of (S) -2- (6-methoxynaphthyl-2-yl) propionic acid was dissolved in 250 ml of 1,2-dichloroethane and 0.1 ml of dimethylformamide and 7.8 ml of thionyl chloride were added. After stirring at 40 ° C. for 2.5 hours, the solvent and excess thionyl chloride were distilled off under reduced pressure to obtain 20.5 g of the desired product as a solid.
1H-NMR(CDCl3) δ(ppm): 1.66(3H, d), 3.71(3H, s), 4.24(1H, q),7.12∼7.76(6H, m)1 H-NMR (CDCl 3) δ (ppm): 1.66 (3H, d), 3.71 (3H, s), 4.24 (1H, q), 7.12 to 7.76 (6H, m)
실시예 1b: N-[(2S)-2-(6-메톡시나프틸-2-일)프로피오닐]-(3S)-7,8-디플루오로-2,3-디히드로-3-메틸-4H[1,4]벤족사진의 제조Example 1b N-[(2S) -2- (6-methoxynaphthyl-2-yl) propionyl]-(3S) -7,8-difluoro-2,3-dihydro-3- Preparation of Methyl-4H [1,4] benzoxazine
30ml의 디클로로메탄에 3.95g의 (RS)-7,8-디플루오로-2,3-디히드로-3-메틸-4H[1,4]벤족사진을 녹였다. 여기에 30ml의 디클로로메탄에 녹인 2.91g의 (S)-2-(6-메톡시나프틸-2-일)프로피오닐 클로라이드를 실온에서 적가하였다. 8시간동안 교반한 후 30ml의 12% 염산용액을 가하였다. 물층은 회수하여 라세미화에 사용한다. 그리고 유기층은 물로 세척 후 MgSO4로 건조시키고 활성탄을 처리 후 여과하였다. 용매를 감압증류 제거하고 얼음용기 하에서 50ml의 헥산을 가하여 생성된 고체를 여과하여 2.55g의 목적 생성물을 수득하였다. 그리고 헥산 여과액은 회수하여 라세미화에 사용한다.3.95 g of (RS) -7,8-difluoro-2,3-dihydro-3-methyl-4H [1,4] benzoxazine was dissolved in 30 ml of dichloromethane. To this was added 2.91 g of (S) -2- (6-methoxynaphthyl-2-yl) propionyl chloride dissolved in 30 ml of dichloromethane dropwise at room temperature. After stirring for 8 hours, 30 ml of 12% hydrochloric acid solution was added. The water layer is recovered and used for racemization. The organic layer was washed with water, dried over MgSO 4, and treated with activated carbon and filtered. The solvent was distilled off under reduced pressure, and 50 ml of hexane was added under an ice container, and the resulting solid was filtered to obtain 2.55 g of the desired product. The hexane filtrate is recovered and used for racemization.
m.p. 113∼114℃m.p. 113 ~ 114 ℃
[α]D20+66.5(c=1.4, CHCl3)[α] D 20 +66.5 (c = 1.4, CHCl 3)
UV, λ(nm): 232UV, λ (nm): 232
1H-NMR(DMSO-d6) δ(ppm): 0.49(3H, d), 1.42(3H, d), 3.83(3H, s),1 H-NMR (DMSO-d 6) δ (ppm): 0.49 (3H, d), 1.42 (3H, d), 3.83 (3H, s),
4.1∼4.3(2H, m), 4.54(1H, q), 4.8(1H, m),4.1 to 4.3 (2H, m), 4.54 (1H, q), 4.8 (1H, m),
6.80∼7.81(8H, m)6.80-7.81 (8H, m)
19F-NMR(DMSO-d6) δ(ppm, C6F6): 20.3(1F), 1.57(1F)19F-NMR (DMSO-d6) δ (ppm, C6F6): 20.3 (1F), 1.57 (1F)
원소분석치 C23H21F2NO3Elemental Analysis C23H21F2NO3
실측치 % C 69.70 H 5.33 N 3.53 F 9.54Found% C 69.70 H 5.33 N 3.53 F 9.54
계산치 % C 69.54 H 5.33 N 3.52 F 9.56Calculated% C 69.54 H 5.33 N 3.52 F 9.56
실시예 1c: (S)-7,8-디플루오로-2,3-디히드로-3-메틸-4H[1,4]벤족사진의 제조Example 1c: Preparation of (S) -7,8-difluoro-2,3-dihydro-3-methyl-4H [1,4] benzoxazine
20ml의 초산에 20ml의 염산과 1.3g의 N-[(2S)-2-(6-메톡시나프틸-2-일)프로피오닐]-(3S)-7,8-디플루오로-2,3-디히드로-3-메틸-4H[1,4]벤족사진을 가하고 9시간동안 가열 환류하였다. 초산을 감압증류 제거한 후 얼음용기 하에서 물을 첨가하였다. 이 때 생성되는 고체를 여과하고 물로 세척하였다. 여과액을 10N 수산화나트륨 수용액으로 pH 9로 맞추었다. 디클로로메탄으로 추출한 후 소금물로 세척하고 유기층을 MgSO4로 건조시키고 여과하였다. 용매를 감압증류 제거하여 0.61g의 목적물을 노란 오일상으로 수득하였다.In 20 ml of acetic acid, 20 ml of hydrochloric acid and 1.3 g of N-[(2S) -2- (6-methoxynaphthyl-2-yl) propionyl]-(3S) -7,8-difluoro-2, 3-dihydro-3-methyl-4H [1,4] benzoxazine was added and heated to reflux for 9 hours. Acetic acid was distilled off under reduced pressure and water was added under an ice container. The resulting solid was filtered off and washed with water. The filtrate was adjusted to pH 9 with 10N aqueous sodium hydroxide solution. Extracted with dichloromethane and washed with brine, the organic layer was dried over MgSO 4 and filtered. The solvent was distilled off under reduced pressure to yield 0.61 g of the desired product as a yellow oil.
[α]D20-8.9(c=3.5, CHCl3)[α] D 20 -8.9 (c = 3.5, CHCl 3)
UV, λ(nm): 244, 297UV, λ (nm): 244, 297
1H-NMR(DMSO-d6) δ(ppm): 1.09(3H, d), 3.42(1H, m), 3.67(1H, dd),1 H-NMR (DMSO-d 6) δ (ppm): 1.09 (3H, d), 3.42 (1H, m), 3.67 (1H, dd),
4.24(1H, dd), 5.9(1H, s), 6.31(1H, ddd),4.24 (1H, dd), 5.9 (1H, s), 6.31 (1H, ddd),
6.66(1H, ddd)6.66 (1 H, ddd)
19F-NMR(DMSO-d6) δ(ppm, C6F6): 9.36(1F), 0.37(1F)19F-NMR (DMSO-d6) δ (ppm, C6F6): 9.36 (1F), 0.37 (1F)
원소분석치 C9H9F2NOElemental Analysis C9H9F2NO
실측치 % C 58.45 H 4.78 N 7.72 F 20.30Found% C 58.45 H 4.78 N 7.72 F 20.30
계산치 % C 58.38 H 4.90 N 7.57 F 20.52Calculated% C 58.38 H 4.90 N 7.57 F 20.52
실시예 2: (RS)-7,8-디플루오로-2,3-디히드로-3-메틸-4H[1,4]벤족사진의 제조Example 2: Preparation of (RS) -7,8-difluoro-2,3-dihydro-3-methyl-4H [1,4] benzoxazine
실시예 1b에서 회수한 헥산 여과액을 농축하여 실시예 1c와 같은 방법으로 반응시키고 여과하여 얻은 물층을 실시예 1b에서 회수한 물층과 혼합하였다. 수용액을 10N 수산화나트륨 수용액으로 pH 9로 맞추었다. 디클로로메탄으로 추출한 후 소금물로 세척하고 유기층을 MgSO4로 건조시키고 여과하였다. 용매를 감압증류 제거하여 2.37g의 (R)-7,8-디플루오로-2,3-디히드로-3-메틸-4H[1,4]벤족사진((S)-나프록센) 유도체로 전환 후 (RS)-1 화합물(HPLC분석 R : S = 86 : 14)을 회수하였다. 여기에 0.81ml의 메탄설폰산을 가하고 110℃에서 13시간동안 교반하였다. 반응물에 에틸아세테이트를 가하고 탄산수소나트륨 수용액과 소금물로 세척하였다. 유기층을 MgSO4로 건조시키고 실리카겔을 깔고 여과한 후 용매를 감압증류 제거하여 2.13g의 목적물을 노란 오일상으로 수득하였다.The hexane filtrate recovered in Example 1b was concentrated, reacted in the same manner as in Example 1c, and the water layer obtained by filtration was mixed with the water layer recovered in Example 1b. The aqueous solution was adjusted to pH 9 with 10N aqueous sodium hydroxide solution. Extracted with dichloromethane and washed with brine, the organic layer was dried over MgSO 4 and filtered. The solvent was distilled off under reduced pressure to convert 2.37 g of (R) -7,8-difluoro-2,3-dihydro-3-methyl-4H [1,4] benzoxazine ((S) -naproxen) derivative. After (RS) -1 compound (HPLC analysis R: S = 86: 14) was recovered. 0.81 ml of methanesulfonic acid was added thereto and stirred at 110 ° C. for 13 hours. Ethyl acetate was added to the reaction mixture, and the mixture was washed with an aqueous sodium bicarbonate solution and brine. The organic layer was dried over MgSO 4, filtered over silica gel, and the solvent was evaporated under reduced pressure to yield 2.13 g of the desired substance as a yellow oil.
[α]D20 0(c=3.5, CHCl3)[α] D 2 0 0 (c = 3.5, CHCl 3)
본 발명은 고광학순도를 갖는 (S)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진 유도체 (S)-1 화합물을 저렴하게 제조할 수 있는 방법을 제공하며, 또한 상기 화합물의 제조과정에서 발생하는 미반응된 (R)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진 유도체 (R)-1 화합물을 라세미화하는 방법을 제공하는 효과를 갖는다The present invention provides a low-cost (S) -3-alkyl-7,8-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine derivative (S) -1 compound with high optical purity. And an unreacted (R) -3-alkyl-7,8-dihalogeno-2,3-dihydro-4H [1,4] benzone that occurs during the preparation of the compound. Has the effect of providing a method of racemizing a photographic derivative (R) -1 compound
본 발명의 단순한 변형 내지 변경은 이 분야의 통상의 지식을 가진 자에 의하여 용이하게 이용될 수 있으며, 이러한 변형이나 변경은 모두 본 발명의 영역에 포함되는 것으로 볼 수 있다.Simple modifications and variations of the present invention can be readily used by those skilled in the art, and all such variations or modifications can be considered to be included within the scope of the present invention.
Claims (9)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP35791098A JP3201998B2 (en) | 1998-12-16 | 1998-12-16 | Method for producing (S) -benzoxazine derivative and method for racemizing (R) -benzoxazine derivative |
JP10-357910 | 1998-12-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20000047396A KR20000047396A (en) | 2000-07-25 |
KR100320772B1 true KR100320772B1 (en) | 2002-01-17 |
Family
ID=18456573
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019990016338A KR100320772B1 (en) | 1998-12-16 | 1999-05-07 | Process for Preparation of (S)-Benzoxazine Derivatives and Process for Racemization of (R)-Benzoxazine Derivatives |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP3201998B2 (en) |
KR (1) | KR100320772B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100397491B1 (en) * | 2000-12-05 | 2003-09-13 | 이수화학 주식회사 | Optically active (S)-benzoxazine derivatives and preparing method of the same |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01175975A (en) * | 1987-12-29 | 1989-07-12 | Dai Ichi Seiyaku Co Ltd | Production of (s)-benzoxazine derivative |
WO1989007596A1 (en) * | 1988-02-15 | 1989-08-24 | Farmitalia Carlo Erba S.R.L. | New 1,4-benzoxazine and 1,4-benzothiazine derivatives and process for their preparation |
EP0619311A1 (en) * | 1992-10-07 | 1994-10-12 | Derivados Del Etilo, S.A. | Process for obtaining benzoxazines useful for the synthesis of ofloxacin, levofloxacin and derivatives thereof |
US5550125A (en) * | 1994-02-03 | 1996-08-27 | Synthelabo | 3-(2-aminomethyl)-4-[3-trifluoromethyl)benzoyl]-3-4 dihydro-2h-1,4-benzoxazine derivatives and their therapeutic application |
-
1998
- 1998-12-16 JP JP35791098A patent/JP3201998B2/en not_active Expired - Fee Related
-
1999
- 1999-05-07 KR KR1019990016338A patent/KR100320772B1/en not_active IP Right Cessation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01175975A (en) * | 1987-12-29 | 1989-07-12 | Dai Ichi Seiyaku Co Ltd | Production of (s)-benzoxazine derivative |
WO1989007596A1 (en) * | 1988-02-15 | 1989-08-24 | Farmitalia Carlo Erba S.R.L. | New 1,4-benzoxazine and 1,4-benzothiazine derivatives and process for their preparation |
EP0619311A1 (en) * | 1992-10-07 | 1994-10-12 | Derivados Del Etilo, S.A. | Process for obtaining benzoxazines useful for the synthesis of ofloxacin, levofloxacin and derivatives thereof |
US5550125A (en) * | 1994-02-03 | 1996-08-27 | Synthelabo | 3-(2-aminomethyl)-4-[3-trifluoromethyl)benzoyl]-3-4 dihydro-2h-1,4-benzoxazine derivatives and their therapeutic application |
Also Published As
Publication number | Publication date |
---|---|
JP2000178265A (en) | 2000-06-27 |
KR20000047396A (en) | 2000-07-25 |
JP3201998B2 (en) | 2001-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100914396B1 (en) | Process for the preparation of benzoxazine derivatives and intermediates therefor | |
US5332857A (en) | 3,5-dihydroxy-6,8-nonadienoic acids and derivatives as hypocholesterolemic agents | |
US4665212A (en) | Process for preparing 2-(4-hydroxyphenoxy) alkanoic acid compounds | |
KR100320772B1 (en) | Process for Preparation of (S)-Benzoxazine Derivatives and Process for Racemization of (R)-Benzoxazine Derivatives | |
KR100511534B1 (en) | Amide compound, process for the production | |
JP2003335756A (en) | Method for producing aromatic aldehyde and chiral diol | |
EP1205476A1 (en) | Process for the synthesis of N-(mercaptoacyl)-amino acids derivatives from alpha-substituted acrylic acids | |
JP2000351776A (en) | Production of optically active homocysteinethiolactone salt and its intermediate | |
FR2540873A1 (en) | NOVEL INTERMEDIATES FOR THE PRODUCTION OF 2- (2-AMINOTHIAZOL-4-YL) GLYOXYLIC ACID DERIVATIVES OR ONE OF ITS SALTS AND THE PROCESS FOR THE PRODUCTION OF SAID INTERMEDIATES | |
KR0142428B1 (en) | Process for preparing 1,4-bridged cyclohexane carboxylic acid derivatives and their use | |
US4577025A (en) | Method of preparing α-aromatic propionic acids and intermediates thereof | |
BE858864A (en) | NEW ESTERS OF PHENYL- AND PYRIDINE-3-CARBOXYLIC ACIDS AND PROCESS FOR THEIR PREPARATION | |
JP4005168B2 (en) | Process for producing optically active 2-aryloxypropionic acid | |
EP1735297B1 (en) | Synthesising method and benzoxathiepine intermediates | |
US4760172A (en) | Process for the preparation of optically active 2-(4-methoxyphenoxy) propionic acid | |
JPH0124782B2 (en) | ||
EP0160241B1 (en) | Process for producing an alpha-aromatic group substituted alkanoic acid derivative | |
JP3569877B2 (en) | Method for producing m-substituted-α-hydroxymethylstyrene derivative and 3-chloro-α-bromostyrene | |
WO2000056716A1 (en) | Synthesis of 3-amino-3-aryl propanoates | |
EP1716088A1 (en) | Catalytic asymmetric synthesis of optically active alpha-halo-car bonyl compounds | |
JP2940395B2 (en) | Preparation of oxyglutarate derivatives | |
JP2923692B2 (en) | Enzymatic resolution method | |
FR2472571A1 (en) | PROCESS FOR THE PREPARATION OF HALOGENO-VINCAMINIC AND HALOGENO-APOVINCAMINIC ESTERS DERIVATIVES | |
EP0179487A1 (en) | 2-Phenylpropionic acid esters, method for optical resolution thereof and optically active substance thereof | |
KR100755151B1 (en) | New Process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20090105 Year of fee payment: 8 |
|
LAPS | Lapse due to unpaid annual fee |